The Carlyle Group, a global alternative asset manager, has acquired a minority stake in Ambio, a US-based global peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO), from specialist healthcare fund MVM Partners.
British pharma giant GlaxoSmithKline (GSK) is set to lay off 650 employees in its US operations in line with a global restructuring strategy announced in July this year.
Olon, an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has acquired a generics chemical operations API manufacturing facility in Mahad, India.
Ireland-based Shire has completed its previously announced $2.4bn sale its Oncology business to French pharmaceutical firm Servier.
Specialty biopharmaceutical firm Emergent BioSolutions has signed an agreement to acquire Adapt Pharma in a deal valued at around $735m.
Perrigo, a global healthcare company, said that its board of directors approved a plan to separate its Prescription Pharmaceuticals (Rx) business following a previously announced strategic portfolio review.
Abzena said that it has completed the GMP drug substance manufacture of an ABZENA Inside product that was originally humanized using the company’s Composite Human Antibody platform.
LEO Pharma, a Danish firm focused on developing drugs for dermatologic and thrombotic patients, has agreed to acquire the global prescription dermatology business of Bayer for an undisclosed price.
Biopharmaceutical firm Amgen has broken ground on its next-generation biomanufacturing facility in Rhode Island, US.
Pfizer has unveiled plans to invest $465m for the development of a new sterile injectable pharmaceutical production facility in Michigan, US.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.